2023
DOI: 10.1021/acscentsci.3c01125
|View full text |Cite
|
Sign up to set email alerts
|

Inserting “OFF-to-ON” BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells

Abigail E. Reese,
Fabio de Moliner,
Lorena Mendive-Tapia
et al.

Abstract: The essential functions that cytokine/immune cell interactions play in tissue homeostasis and during disease have prompted the molecular design of targeted fluorophores to monitor their activity in real time. Whereas activatable probes for imaging immune-related enzymes are common, many immunological functions are mediated by binding events between cytokines and their cognate receptors that are hard to monitor by live-cell imaging. A prime example is interleukin-33 (IL-33), a key cytokine in innate and adaptiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 78 publications
(135 reference statements)
0
2
0
Order By: Relevance
“…Beyond fluorescence labeling, fUAAs with environment-sensing fluorogenicity, namely fluorogenic unnatural amino acids (FUAAs), further enable background-free visualization of biomolecular interactions, especially for protein–ligand binding or PPIs. Despite several applications of fluorogenic cores (e.g., BODIPY and NBD) and their analogs in FUAAs, , the development of small and biocompatible fluorogenic unnatural amino acids remains in high demand but still presents significant challenges.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Beyond fluorescence labeling, fUAAs with environment-sensing fluorogenicity, namely fluorogenic unnatural amino acids (FUAAs), further enable background-free visualization of biomolecular interactions, especially for protein–ligand binding or PPIs. Despite several applications of fluorogenic cores (e.g., BODIPY and NBD) and their analogs in FUAAs, , the development of small and biocompatible fluorogenic unnatural amino acids remains in high demand but still presents significant challenges.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Vendrell et al already have experience in developing fluorogenic peptide probes for in vivo labeling. For instance, they showed efficient linker-free coupling of BODIPY to tryptophane. This time they envisaged a fluorogenic protein probe for immunosuppressive drug monitoring using the immunophilins peptidylprolyl isomerase A (PPIA) and FK506-binding protein (FKBP12) as protein receptors that tightly bind immunosuppressive drugs such as tacrolimus. A key aspect of the design was a short linker between the fluorophore and the protein so that the binding of a relatively small ligand, such as the cyclic peptide tacrolimus, would result in the desired turn-on fluorescence.…”
mentioning
confidence: 99%